E-viri
Recenzirano
Odprti dostop
-
Viswanathan, Srinivas R.; Ha, Gavin; Hoff, Andreas M.; Wala, Jeremiah A.; Carrot-Zhang, Jian; Whelan, Christopher W.; Haradhvala, Nicholas J.; Freeman, Samuel S.; Reed, Sarah C.; Rhoades, Justin; Polak, Paz; Cipicchio, Michelle; Wankowicz, Stephanie A.; Wong, Alicia; Kamath, Tushar; Zhang, Zhenwei; Gydush, Gregory J.; Rotem, Denisse; Love, J. Christopher; Getz, Gad; Gabriel, Stacey; Zhang, Cheng-Zhong; Dehm, Scott M.; Nelson, Peter S.; Van Allen, Eliezer M.; Choudhury, Atish D.; Adalsteinsson, Viktor A.; Beroukhim, Rameen; Taplin, Mary-Ellen; Meyerson, Matthew
Cell, 07/2018, Letnik: 174, Številka: 2Journal Article
Nearly all prostate cancer deaths are from metastatic castration-resistant prostate cancer (mCRPC), but there have been few whole-genome sequencing (WGS) studies of this disease state. We performed linked-read WGS on 23 mCRPC biopsy specimens and analyzed cell-free DNA sequencing data from 86 patients with mCRPC. In addition to frequent rearrangements affecting known prostate cancer genes, we observed complex rearrangements of the AR locus in most cases. Unexpectedly, these rearrangements include highly recurrent tandem duplications involving an upstream enhancer of AR in 70%–87% of cases compared with <2% of primary prostate cancers. A subset of cases displayed AR or MYC enhancer duplication in the context of a genome-wide tandem duplicator phenotype associated with CDK12 inactivation. Our findings highlight the complex genomic structure of mCRPC, nominate alterations that may inform prostate cancer treatment, and suggest that additional recurrent events in the non-coding mCRPC genome remain to be discovered. Display omitted •Linked-read genome sequencing of mCRPC resolves haplotypes and rearrangements•CDK12 inactivation is associated with a global tandem duplication phenotype•A majority of cases have duplications of an enhancer of the androgen receptor•Progression on androgen pathway inhibitors is associated with gains in AR and AR enhancer Linked-read genome sequencing data from patients highlight that amplification of an enhancer upstream of the androgen receptor locus is a key feature of metastatic castration-resistant prostate cancer.
Avtor
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|
Vir: Osebne bibliografije
in: SICRIS
To gradivo vam je dostopno v celotnem besedilu. Če kljub temu želite naročiti gradivo, kliknite gumb Nadaljuj.